Financial Highlights

Revenue growth up

 +17%

Revenue $ million

2005 1,599.3
2004 1,363.2

Revenue growth over the
last five years $ million

2005 1,599.3
2004 1,363.2
2003 1,211.6
2002 1,023.3
2001 845.1

Sources of revenue $ million

Sources of revenue %
1 ADDERALL XR 730.8
2 CARBATROL 72.1
3 PENTASA 136.1
4 AGRYLIN/XAGRID 92.8
5 FOSRENOL 53.5
6 REPLAGAL* 41.3
7 Other 201.1
8 Royalty income 242.9
9 Licensing and Development
and other		 28.7
  Total 1,599.3

Sources of revenue %

Sources of revenue $m
1 ADDERALL XR 46
2 CARBATROL 4
3 PENTASA 8
4 AGRYLIN/XAGRID 6
5 FOSRENOL 3
6 REPLAGAL* 3
7 Other 13
8 Royalty income 15
9 Licensing and Development
and other		 2
  Total 100

Revenue by location
$ million

Revenue by reporting segment %
1 North America 1,233.5
2 Rest of the world 365.8